GJC2
Gap junction gamma-2 protein
Also known as: CX46.6, CX47, CXG2_HUMAN, GJA12, SPG44
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q5T442
- Gene
- GJC2
- Ensembl
- ENSG00000198835
- Chromosome
- 1
- Canonical length
- 439 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a gap junction protein. Gap junction proteins are members of a large family of homologous connexins and comprise 4 transmembrane, 2 extracellular, and 3 cytoplasmic domains. This gene plays a key role in central myelination and is involved in peripheral myelination in humans. Defects in this gene are the cause of autosomal recessive Pelizaeus-Merzbacher-like disease-1. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
439 residues, UniProt reviewed canonical sequence.
>Q5T442|GJC2
1 MTNMSWSFLT RLLEEIHNHS TFVGKVWLTV LVVFRIVLTA VGGEAIYSDE QAKFTCNTRQ
61 PGCDNVCYDA FAPLSHVRFW VFQIVVISTP SVMYLGYAVH RLARASEQER RRALRRRPGP
121 RRAPRAHLPP PHAGWPEPAD LGEEEPMLGL GEEEEEEETG AAEGAGEEAE EAGAEEACTK
181 AVGADGKAAG TPGPTGQHDG RRRIQREGLM RVYVAQLVAR AAFEVAFLVG QYLLYGFEVR
241 PFFPCSRQPC PHVVDCFVSR PTEKTVFLLV MYVVSCLCLL LNLCEMAHLG LGSAQDAVRG
301 RRGPPASAPA PAPRPPPCAF PAAAAGLACP PDYSLVVRAA ERARAHDQNL ANLALQALRD
361 GAAAGDRDRD SSPCVGLPAA SRGPPRAGAP ASRTGSATSA GTVGEQGRPG THERPGAKPR
421 AGSEKGSASS RDGKTTVWILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GJC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 67 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 67 nTPM
- midbrain: 25 nTPM
- hippocampal formation: 17 nTPM
- hypothalamus: 11 nTPM
- basal ganglia: 9.9 nTPM
- amygdala: 8.4 nTPM
Single-cell type
- lymphatic endothelial cells: 58 nCPM
- oligodendrocytes: 41 nCPM
- cone photoreceptor cells: 12 nCPM
- medullary thymic epithelial cells: 9.6 nCPM
- pdcs: 8.8 nCPM
- smooth muscle cells: 7.7 nCPM
Immune cell
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 96 nTPM
- medulla oblongata: 85 nTPM
- cerebellum: 74 nTPM
- pons: 59 nTPM
- midbrain: 58 nTPM
- basal ganglia: 56 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GJC2.
Disease | AllUniProt
Conditions GJC2 is implicated in, by any mechanism.
- Leukodystrophy, hypomyelinating, 2 (HLD2) MIM:608804
- Spastic paraplegia 44, autosomal recessive (SPG44) MIM:613206
- Lymphatic malformation 3 (LMPHM3) MIM:613480
Disease | GeneticClinVar
77 pathogenic / likely-pathogenic of 430 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hypomyelinating leukodystrophy 2
- Spastic paraplegia
- Lymphatic malformation 3
- Hereditary spastic paraplegia 44
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.23
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.87
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- gap junction channel activity
- gap junction channel activity involved in cell communication by electrical coupling
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GJC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GJC2 as an antibody target. Whether an autoantibody or antibody against GJC2 could matter depends on whether native GJC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GJC2 is annotated at the cell surface, where native GJC2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GJC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...